USD 6.5
(8.15%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -39.35 Million USD | -98.87% |
2022 | 23.08 Million USD | 194.02% |
2021 | 7.85 Million USD | -69.73% |
2020 | 25.94 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -15.45 Million USD | 2.31% |
2024 Q2 | -8 Million USD | 120.48% |
2023 Q3 | -2.72 Million USD | -81.93% |
2023 FY | - USD | -98.87% |
2023 Q2 | -1.49 Million USD | -47.66% |
2023 Q1 | -1.01 Million USD | -115.04% |
2023 Q4 | -6.45 Million USD | -137.0% |
2022 Q1 | -250.3 Thousand USD | 73.45% |
2022 FY | - USD | 194.02% |
2022 Q4 | 6.74 Million USD | 0.93% |
2022 Q3 | 6.68 Million USD | 2479.04% |
2022 Q2 | -280.87 Thousand USD | -12.21% |
2021 Q4 | -942.83 Thousand USD | -137.54% |
2021 Q2 | 6.11 Million USD | 671.96% |
2021 FY | - USD | -69.73% |
2021 Q3 | -396.91 Thousand USD | -106.49% |
2021 Q1 | -1.06 Million USD | 0.0% |
2020 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
ATI Physical Therapy, Inc. | 82.86 Million USD | 147.487% |
Assure Holdings Corp. | -19.82 Million USD | -98.502% |
Novo Integrated Sciences, Inc. | -5.84 Million USD | -572.782% |
Panamera Holdings Corporation | -7.12 Million USD | -452.631% |